C4 Therapeutics Inc Capital Reinvestment Ratio
C4 Therapeutics Inc capital reinvestment ratio. C4 Therapeutics Inc (CCCC) has a Capital Reinvestment Ratio of 0.02x as of June 2019, meaning it reinvests 0% of its operating cash flow ($36.91 Million) in capital expenditures ($641.00K). Check C4 Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of C4 Therapeutics Inc (2019–2019)
Capital reinvestment ratio of C4 Therapeutics Inc from 2019 to 2019. This chart tracks C4 Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore C4 Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
C4 Therapeutics Inc Capital Reinvestment Ratio by Year (2019–2019)
C4 Therapeutics Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see cash flow conversion of C4 Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.02x | $55.61 Million | $1.35 Million | — |